962 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SNY Sanofi $43.75 $109.14B Sell
Article Searches
Why Sanofi Won't Try To Buy Bristol-Myers https://seekingalpha.com/article/4243375-sanofi-try-buy-bristol-myers?source=feed_sector_healthcare Feb 22, 2019 - There are twitter rumors that Sanofi wants to buy Bristol-Myers.Strategically, it fits the profile of an acquisition Sanofi would want.However, there are a number of important reasons why it is unlike
Regeneron and Sanofi prevail in review of Amgen's IL-4 receptor patent https://seekingalpha.com/news/3434167-regeneron-sanofi-prevail-review-amgens-ilminus-4-receptor-patent?source=feed_news_all Feb 16, 2019 - Regeneron Pharmaceuticals (NASDAQ:REGN) and development partner Sanofi (NASDAQ:SNY) announce that the USPTO has invalidated 17 claims as obvious of U.S. Patent No. 8,679,487 owned by Amgen's (NASDAQ:A
Ascendis Pharma Files IND for Hypoparathyroidism Candidate http://www.zacks.com/stock/news/354249/ascendis-pharma-files-ind-for-hypoparathyroidism-candidate?cid=CS-ZC-FT-354249 Feb 13, 2019 - Ascendis Pharma (ASND) submits regulatory application to initiate a phase II study in the United States on its hypoparathyroidism therapy candidate, TransCon PTH.
Sanofi and Regeneron to cut price of Praluent https://seekingalpha.com/news/3431580-sanofi-regeneron-cut-price-praluent?source=feed_news_all Feb 11, 2019 - Regeneron Pharmaceuticals (NASDAQ:REGN) and development partner Sanofi (NASDAQ:SNY) will adjust the U.S. list price of cholesterol med Praluent (alirocumab) to $5,850 effective next month. Out-of-pock
Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs http://www.zacks.com/stock/news/353203/pharma-stock-roundup-q4-earnings-at-mrk-lly-chmp-nod-for-several-drugs?cid=CS-ZC-FT-353203 Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/353200/alnylams-alny-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-353200 Feb 08, 2019 - Alnylam (ALNY) incurs wider year-over-year loss in the fourth quarter of 2018.
Sanofi (SNY) CEO Olivier Brandicourt on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4239163-sanofi-sny-ceo-olivier-brandicourt-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 07, 2019 -
Sanofi 2018 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4238983-sanofi-2018-q4-results-earnings-call-slides?source=feed_sector_healthcare Feb 07, 2019 -
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth http://www.zacks.com/stock/news/352788/sanofi-sny-q4-earnings-top-genzyme-unit-drives-sales-growth?cid=CS-ZC-FT-352788 Feb 07, 2019 - Sanofi (SNY) beat estimates for earnings and missed the same for sales in the fourth quarter. The Specialty Care unit drove top-line growth.
Sanofi guides +5% net income for 2019 https://seekingalpha.com/news/3430599-sanofi-guides-plus-5-percent-net-income-2019?source=feed_news_all Feb 07, 2019 - Sanofi (NASDAQ:SNY) expects net income to increase by 3% to 5% in 2019 through a combination of new drug launches and reorganization.Sanofi's Q4 net income was up 4.3% in constant currency to 1.36B eu

Pages: 123456...97

Page 1>

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
ABT Abbott Laboratories NYSE $67.67 $118.71B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Sanofi
SNY - Google Finance https://www.google.com/finance?q=SNY Industry related info and international coverage Summary News
SNY - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=SNY Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options